We have extended an invitation to Gilead Sciences, inviting their Chief Science Officer to be interviewed by Mike Adams about remdesivir and the recent claim by Dr. Bryan Ardis that remdesivir is derived from peptides whose origin is traced back to snake venom. We believe the public deserves to hear both sides of every issue, and we believe that Gilead deserves an opportunity to respond to these allegations and to answer additional questions we have about remdesivir safety vs. risks.